{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:51:47Z","timestamp":1790787107930,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41409-025-02544-y","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T06:21:38Z","timestamp":1741674098000},"page":"640-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patients"],"prefix":"10.1038","volume":"60","author":[{"given":"Olivia","family":"Lira-Lara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Robles-Nasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-3600","authenticated-orcid":false,"given":"Juan Carlos","family":"Olivares-Gazca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-5185","authenticated-orcid":false,"given":"Mohamed","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rivera-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae","family":"Garc\u00eda-V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lavoignet-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica D.","family":"Salgado-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-6427","authenticated-orcid":false,"given":"David","family":"Gomez-Almaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"G\u00f3mez-De-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo J.","family":"Ruiz-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-0653","authenticated-orcid":false,"given":"Guillermo J.","family":"Ruiz-Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2544_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"B Sharrack","year":"2020","unstructured":"Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, et al. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Bone Marrow Transplant. 2020;55:283\u2013306.","journal-title":"Bone Marrow Transplant"},{"key":"2544_CR2","doi-asserted-by":"crossref","unstructured":"Alexander T, Sharrack B, Rovira M, Saccardi R, Farge D, Snowden JA, et al. Autoimmune disease. In: The EBMT handbook. Cham: Springer International Publishing; 2024. p. 825\u201336.","DOI":"10.1007\/978-3-031-44080-9_92"},{"key":"2544_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/SPC.0000000000000466","volume":"13","author":"A Ismail","year":"2019","unstructured":"Ismail A, Sharrack B, Saccardi R, Moore JJ, Snowden JA. Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. Curr Opin Support Palliat Care. 2019;13:394\u2013401.","journal-title":"Curr Opin Support Palliat Care"},{"key":"2544_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.647425","volume":"12","author":"I Murrieta-\u00c1lvarez","year":"2021","unstructured":"Murrieta-\u00c1lvarez I, Cantero-Fortiz Y, Le\u00f3n-Pe\u00f1a AA, Olivares-Gazca JC, Priesca-Mar\u00edn JM, Ruiz-Delgado GJ, et al. The 1,000th transplant for multiple sclerosis and other autoimmune disorders at the HSCT-M\u00e9xico Program: a myriad of experiences and knowledge. Front Neurol. 2021;12:1\u20136.","journal-title":"Front Neurol"},{"key":"2544_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41409-024-02397-x","volume":"59","author":"T Silfverberg","year":"2024","unstructured":"Silfverberg T, Zjukovskaja C, Noui Y, Carlson K, Nahimi A, Erik A, et al. BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis. Bone Marrow Transplant. 2024;59:1601\u201310.","journal-title":"Bone Marrow Transplant"},{"key":"2544_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000469655","volume":"137","author":"GJ Ruiz-Arg\u00fcelles","year":"2017","unstructured":"Ruiz-Arg\u00fcelles GJ, Le\u00f3n-Pe\u00f1a AA, Le\u00f3n-Gonz\u00e1lez M, Nu\u00f1ez-Cortes AK, Olivares-Gazca JC, Murrieta-Alvarez I, et al. A feasibility study of the full outpatient conduction of hematopoietic transplants in persons with multiple sclerosis employing autologous non-cryopreserved peripheral blood stem cells. Acta Haematol. 2017;137:214\u20139.","journal-title":"Acta Haematol"},{"key":"2544_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ctr.13567","volume":"33","author":"RP Gale","year":"2019","unstructured":"Gale RP, G\u00f3mez-Cruz GB, Olivares-Gazca JC, Le\u00f3n-Pe\u00f1a AA, G\u00f3mez-Almaguer D, G\u00f3mez-De-Le\u00f3n A, et al. Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosis. Clin Transplant. 2019;33:1.","journal-title":"Clin Transplant"},{"key":"2544_CR8","doi-asserted-by":"crossref","unstructured":"Olivares-Gazca JC, Gale RP, S\u00e1nchez-Bonilla D, Gallardo-P\u00e9rez MM, Soto-Olvera S, Ruiz-Delgado GJ, et al. SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosis. Hematology. 2023;28.","DOI":"10.1080\/16078454.2022.2164443"},{"key":"2544_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.24245\/rev_hematol.v24i2.9223","volume":"24","author":"J Garces Eisele","year":"2023","unstructured":"Garces Eisele J, Olivares Gazca JC. Pioneering 30 years of hematopoietic stem cell transplants in Puebla, Mexico. Pioneros 30 a\u00f1os de trasplantes de c\u00e9lulas madre hematopoy\u00e9ticas en Puebla, M\u00e9xico. Editorial. Rev Hematol Mex. 2023;24:37\u201345. https:\/\/doi.org\/10.24245\/rev_hematol.v24i2.9223","journal-title":"Rev Hematol Mex"},{"key":"2544_CR10","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.bbmt.2019.12.086","volume":"26","author":"GJ Ruiz-Arguelles","year":"2020","unstructured":"Ruiz-Arguelles GJ, Olivares-Gazca JC, Olivares-Gazca JM, Leon-Pe\u00f1a A, Murrieta-\u00c1lvarez I, Cantero-Fortiz Y, et al. Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in persons with multiple sclerosis after autologous stem cell transplants: experience with the \u201cMexican Method\u201d. Biology Blood Marrow Transplant. 2020;26:S20\u20131.","journal-title":"Biology Blood Marrow Transplant"},{"key":"2544_CR11","unstructured":"Punnapuzha S, Edemobi PK, Elmoheen A. Febrile Neutropenia. 2023 Mar 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"2544_CR12","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1086\/522533","volume":"45","author":"E Castagnola","year":"2007","unstructured":"Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clinical Infectious Diseases. 2007;45:1296\u2013304.","journal-title":"Clinical Infectious Diseases"},{"key":"2544_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/jnnp-2023-331864","volume":"95","author":"T Silfverberg","year":"2023","unstructured":"Silfverberg T, Zjukovskaja C, Ljungman P, Nahimi A, Ahlstrand E, Dreimane A, et al. Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study. J Neurol Neurosurg Psychiatry. 2023;95:125\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2544_CR14","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1212\/WNL.54.11.2147","volume":"54","author":"H Openshaw","year":"2000","unstructured":"Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology. 2000;54:2147\u201350.","journal-title":"Neurology"},{"key":"2544_CR15","first-page":"1","volume":"3","author":"N Tsotsolis","year":"2015","unstructured":"Tsotsolis N, Tsirgogianni K, Kioumis I, Pitsiou G, Baka S, Papaiwannou A, et al. Pneumothorax as a complication of central venous catheter insertion. Ann Transl Med. 2015;3:1\u201310.","journal-title":"Ann Transl Med"},{"key":"2544_CR16","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3390\/jcm9113721","volume":"9","author":"E Koumpis","year":"2020","unstructured":"Koumpis E, Florentin M, Hatzimichael E, Liamis G. Hyponatremia in patients with hematologic diseases. J Clin Med. 2020;9:3721.","journal-title":"J Clin Med"},{"key":"2544_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/sj.bmt.1704688","volume":"34","author":"R Kobayashi","year":"2004","unstructured":"Kobayashi R, Iguchi A, Nakajima M, Sato T, Yoshida M, Kaneda M, et al. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation. Bone Marrow Transplant. 2004;34:975\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"2544_CR18","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ndt\/gfp731","volume":"25","author":"L Young Chul","year":"2010","unstructured":"Young Chul L, Joon Sung P, Chang Hwa L, Sang Cheol B, In Soon K, Chong Myung K, et al. Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. Nephrol Dial Transplant. 2010;25:1524\u201331.","journal-title":"Nephrol Dial Transplant"},{"key":"2544_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJMra2114478","volume":"387","author":"C Basso","year":"2022","unstructured":"Basso C. Myocarditis. N Engl J Med. 2022;387:1488\u2013500.","journal-title":"N Engl J Med"},{"key":"2544_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01217","volume":"25","author":"P Akella","year":"2021","unstructured":"Akella P, Bhatt I, Serhan M, Giri DD, Pastores SM. Toxic \u2018Toxo\u2019 in the heart: cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report. IDCases. 2021;25:e01217.","journal-title":"IDCases"},{"key":"2544_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","volume":"141","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med. 1981;141:758\u201363.","journal-title":"Arch Intern Med"},{"key":"2544_CR22","doi-asserted-by":"crossref","unstructured":"Olivares-Gazca JC, Guerrero-Pesqueira F, Murrieta-Alvarez I, Cantero-Fortiz Y, Le\u00f3n-Pe\u00f1a A, Priesca-Mar\u00edn JM, et al. Splitting the total dose of cyclophosphamide in two blocks apart during the conditioning of autologous hematopoietic stem cell transplantation in multiple sclerosis results in diminished cardiotoxicity: experience in 1000 patients. Rev Invest Clin. 2022;74:1\u20133.","DOI":"10.24875\/RIC.21000206"},{"key":"2544_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrneurol.2017.81","volume":"13","author":"PA Muraro","year":"2017","unstructured":"Muraro PA, Martin R, Mancardi GL, Nicholas R, Sormani MP, Saccardi R. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis. Nat Rev Neurol. 2017;13:1\u201337.","journal-title":"Nat Rev Neurol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02544-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T10:28:14Z","timestamp":1746700094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02544-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2544"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02544-y","relation":{"is-basis-for":[{"id-type":"doi","id":"10.52843\/cassyni.fy15b6","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with Helsinki Declaration and national regulations. The protocol was approved by the Institutional Review Board of the Cl\u00ednica Ruiz (CEI-10-03-24-02). Informed consent was obtained from all participants. The protocol has been registered in ClinicalTrials.govNCT02674217.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}